M. Narabayashi

发表

Nationwide survey on complementary and alternative medicine in cancer patients in Japan.

K. Eguchi, I. Hyodo, N. Amano, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Measurement of interfraction variations in position and size of target volumes in stereotactic body radiotherapy for lung cancer.

Mitsuhiro Nakamura, M. Hiraoka, M. Narabayashi, 2009, International journal of radiation oncology, biology, physics.

Title Characterization of FDG-PET images after stereotactic body radiation therapy for lung cancer

K. Togashi, T. Saga, M. Hiraoka, 2018 .

Characterization of FDG-PET images after stereotactic body radiation therapy for lung cancer.

K. Togashi, T. Saga, M. Hiraoka, 2010, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

UGT1A1*1/*28 and *1/*6 genotypes have no effects on the efficacy and toxicity of FOLFIRI in Japanese patients with advanced colorectal cancer

M. Narabayashi, K. Yamashita, Y. Ando, 2011, Cancer Chemotherapy and Pharmacology.

Pharmacogenetic impact of polymorphisms in the coding region of the UGT1A1 gene on SN‐38 glucuronidation in Japanese patients with cancer

M. Narabayashi, Y. Ando, Y. Sasaki, 2006, Cancer science.

GEFITINIB (IRESSA) INHIBITS THE CYP3A4-MEDIATED FORMATION OF 7-ETHYL-10-(4-AMINO-1-PIPERIDINO)CARBONYLOXYCAMPTOTHECIN BUT ACTIVATES THAT OF 7-ETHYL-10-[4-N-(5-AMINOPENTANOIC ACID)-1-PIPERIDINO]CARBONYLOXYCAMPTOTHECIN FROM IRINOTECAN

M. Narabayashi, Y. Ando, Y. Sasaki, 2005, Drug Metabolism and Disposition.

Phase III study to evaluate the use of high‐dose chemotherapy as consolidation of treatment for high‐risk postoperative breast cancer: Japan Clinical Oncology Group study, JCOG 9208

M. Narabayashi, S. Takashima, M. Ogura, 2007, Cancer science.

Novel single nucleotide polymorphism of UGT1A7 gene in Japanese.

M. Narabayashi, Y. Ando, Y. Sasaki, 2006, Drug metabolism and pharmacokinetics.

Randomized Phase III and Extension Studies of Naldemedine in Patients With Opioid-Induced Constipation and Cancer.

M. Tsutsumi, M. Narabayashi, T. Harada, 2017, Journal of Clinical Oncology.

Differences in the dose–volume metrics with heterogeneity correction status and its influence on local control in stereotactic body radiation therapy for lung cancer

Mitsuhiro Nakamura, M. Hiraoka, M. Narabayashi, 2012, Journal of radiation research.

Differences in dose-volumetric data between the analytical anisotropic algorithm and the x-ray voxel Monte Carlo algorithm in stereotactic body radiation therapy for lung cancer.

Mitsuhiro Nakamura, M. Hiraoka, M. Narabayashi, 2013, Medical dosimetry : official journal of the American Association of Medical Dosimetrists.

Toxicity grading criteria of the Japan Clinical Oncology Group. The Clinical Trial Review Committee of the Japan Clinical Oncology Group.

Y. Shimada, M. Narabayashi, T. Fukutomi, 1993, Japanese journal of clinical oncology.

Association of ATP-binding cassette, sub-family C, number 2 (ABCC2) genotype with pharmacokinetics of irinotecan in Japanese patients with metastatic colorectal cancer treated with irinotecan plus infusional 5-fluorouracil/leucovorin (FOLFIRI).

M. Narabayashi, K. Yamashita, Y. Ando, 2008, Biological & pharmaceutical bulletin.

Fixed dosing and pharmacokinetics of S-1 in Japanese cancer patients with large body surface areas.

M. Narabayashi, Y. Ando, W. Ichikawa, 2009, Annals of oncology : official journal of the European Society for Medical Oncology.

Diagnosis and treatment of akathisia in a cancer patient who cannot stand up or sit down, because of poor performance status: Factors that make the diagnosis of akathisia difficult, and diagnosis clues

M. Narabayashi, Y. Sasaki, C. Kawanishi, 2010, Palliative and Supportive Care.

Detection and treatment of akathisia in advanced cancer patients during adjuvant analgesic therapy with tricyclic antidepressants: Case reports and review of the literature

M. Narabayashi, Y. Sasaki, C. Kawanishi, 2007, Palliative and Supportive Care.

Construction and validation of a practical prognostic index for patients with metastatic breast cancer.

M. Narabayashi, S. Takashima, H. Fukuda, 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Hypomanic episode during recurrent gastric cancer treatment: report of a rare case and literature review.

M. Narabayashi, H. Nakayama, Y. Sasaki, 2012, Japanese journal of clinical oncology.

CYP2A6 and the plasma level of 5‐chloro‐2, 4‐dihydroxypyridine are determinants of the pharmacokinetic variability of tegafur and 5‐fluorouracil, respectively, in Japanese patients with cancer given S‐1

Kazuhiro Araki, Wataru Ichikawa, Fumio Nagashima, 2008, Cancer science.

Safety and effectiveness of stereotactic body radiotherapy for a clinically diagnosed primary stage I lung cancer without pathological confirmation

M. Hiraoka, M. Narabayashi, Y. Nagata, 2014, International Journal of Clinical Oncology.

Effect of bevacizumab combined with boron neutron capture therapy on local tumor response and lung metastasis

M. Narabayashi, K. Ono, Minoru Suzuki, 2014, Experimental and therapeutic medicine.

Radiosensitivity of pimonidazole-unlabelled intratumour quiescent cell population to γ-rays, accelerated carbon ion beams and boron neutron capture reaction.

M. Narabayashi, K. Ono, Y. Sakurai, 2013, The British journal of radiology.

Acute gefitinib-induced pneumonitis

M. Narabayashi, Y. Ando, Y. Sasaki, 2004, International Journal of Clinical Oncology.

Phase I study of cladribine (2-chlorodeoxyadenosine) in lymphoid malignancies. Cladribine Study Group.

Y. Ohashi, M. Narabayashi, R. Suzuki, 1997, Japanese journal of clinical oncology.

Prognostic factors and a predictive model of follicular lymphoma: a 25-year study at a single institution in Japan.

Y. Matsuno, M. Narabayashi, K. Tobinai, 1996, Japanese journal of clinical oncology.

Seven cases of breast cancer recurrence limited to the central nervous system without other visceral metastases

M. Narabayashi, S. Akashi-Tanaka, T. Fukutomi, 2000, Breast cancer.

Prognostic factors in stereotactic body radiotherapy for non-small-cell lung cancer.

M. Hiraoka, M. Narabayashi, Y. Nagata, 2011, International journal of radiation oncology, biology, physics.

Preliminary Report of Late Recurrences, at 5 Years or More, after Stereotactic Body Radiation Therapy for Non-small Cell Lung Cancer

M. Hiraoka, M. Narabayashi, Y. Nagata, 2012, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Re: Role of body surface area in dosing of investigational anticancer agents in adults, 1991-2001.

N. Saijo, M. Ando, M. Narabayashi, 2003, Journal of the National Cancer Institute.

First clinical pharmacokinetic dose-escalation study of sagopilone, a novel, fully synthetic epothilone, in Japanese patients with refractory solid tumors

T. Mukohara, H. Mukai, M. Narabayashi, 2012, Investigational New Drugs.

Impact of multileaf collimator width on intraprostatic dose painting plans for dominant intraprostatic lesion of prostate cancer*

M. Hiraoka, M. Narabayashi, Y. Nagata, 2010, Journal of applied clinical medical physics.

Independent Validation of the Japanese Version of the EORTC QLQ-C15-PAL for Patients With Advanced Cancer.

C. Takigawa, M. Narabayashi, T. Morita, 2015, Journal of pain and symptom management.

Cardiac conduction abnormalities in patients with breast cancer undergoing high-dose chemotherapy and stem cell transplantation

S. Mineishi, M. Narabayashi, K. Tobinai, 2000, Bone Marrow Transplantation.

Genetic testing for UGT1A1*28 and *6 in Japanese patients who receive irinotecan chemotherapy.

M. Narabayashi, K. Yamashita, Y. Ando, 2008, Annals of oncology : official journal of the European Society for Medical Oncology.

Genetic linkage of UGT1A7 and UGT1A9 polymorphisms to UGT1A1*6 is associated with reduced activity for SN-38 in Japanese patients with cancer

M. Narabayashi, Y. Ando, Y. Sasaki, 2007, Cancer Chemotherapy and Pharmacology.

Incidence and Risk Factors of Symptomatic Radiation Pneumonitis in Non-Small-Cell Lung Cancer Patients Treated with Concurrent Chemoradiotherapy and Consolidation Durvalumab.

Young Hak Kim, M. Ogura, M. Narabayashi, 2021, Clinical lung cancer.

Re: UGT1A1*28 genotype and irinotecan-induced neutropenia: dose matters.

M. Narabayashi, Y. Ando, W. Ichikawa, 2008, Journal of the National Cancer Institute.

Mental adjustment to first recurrence and correlated factors in patients with breast cancer

M. Narabayashi, H. Okamura, T. Akechi, 2001, Breast Cancer Research and Treatment.

A late phase II study of RP56976 (docetaxel) in patients with advanced or recurrent breast cancer.

M. Narabayashi, T. Watanabe, N. Horikoshi, 1996, British Journal of Cancer.

Significance of Fractionated Administration of Thalidomide Combined With γ-Ray Irradiation in Terms of Local Tumor Response and Lung Metastasis

M. Narabayashi, K. Ono, Minoru Suzuki, 2014, World journal of oncology.

Usefulness of Daily Fractionated Administration of Wortmannin Combined With γ-Ray Irradiation in Terms of Local Tumor Response and Lung Metastasis

M. Narabayashi, K. Ono, Minoru Suzuki, 2013, World journal of oncology.

Bilateral popliteal artery entrapment syndrome: reemphasis on reading axial tomograms

T. Higashino, M. Narabayashi, S. Noma, 2007, Radiation Medicine.

Title Dose-volume metrics associated with radiation pneumonitis after stereotactic body radiation therapy for lung cancer

M. Hiraoka, M. Narabayashi, Y. Nagata, 2017 .

A phase I trial of docetaxel and 5-day continuous infusion of 5-fluorouracil in patients with advanced or recurrent breast cancer.

M. Narabayashi, K. Itoh, Y. Sasaki, 1998, British Journal of Cancer.

t(11;18)-Bearing Pulmonary Mucosa-Associated Lymphoid Tissue Lymphoma Responding to Cladribine

Y. Matsuno, M. Narabayashi, K. Tobinai, 2004, International journal of hematology.

Efficacy of docetaxel 60 mg/m2 in patients with metastatic breast cancer according to the status of anthracycline resistance.

M. Narabayashi, T. Watanabe, N. Katsumata, 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Improvement of depth dose distribution using multiple-field irradiation in boron neutron capture therapy.

M. Narabayashi, K. Ono, Y. Sakurai, 2015, Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine.

Advances in boron neutron capture therapy (BNCT) at kyoto university - From reactor-based BNCT to accelerator-based BNCT

M. Narabayashi, K. Ono, Minoru Suzuki, 2015, Journal of the Korean Physical Society.

Pilot clinical study of boron neutron capture therapy for recurrent hepatic cancer involving the intra-arterial injection of a (10)BSH-containing WOW emulsion.

M. Narabayashi, K. Ono, Minoru Suzuki, 2014, Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine.

DNA damage induced by boron neutron capture therapy is partially repaired by DNA ligase IV

S. Miyatake, M. Narabayashi, T. Ohnishi, 2016, Radiation and environmental biophysics.

DNA damage induced by boron neutron capture therapy is partially repaired by DNA ligase IV

S. Miyatake, M. Narabayashi, T. Ohnishi, 2015, Radiation and Environmental Biophysics.

Randomized phase III and extension studies: efficacy and impacts on quality of life of naldemedine in subjects with opioid-induced constipation and cancer

M. Tsutsumi, M. Narabayashi, T. Harada, 2018, Annals of oncology : official journal of the European Society for Medical Oncology.

Eyelid metastasis from breast cancer showing marked response to chemotherapy.

H. Tsuda, M. Narabayashi, A. Kaneko, 1995, Japanese journal of clinical oncology.

Histopathological study of corpora amylacea pulmonum.

M. Narabayashi, M. Ohgushi, Y. Imai, 1989, Histology and histopathology.

Feasibility and pharmacokinetic study of a chimeric anti-CD20 monoclonal antibody (IDEC-C2B8, rituximab) in relapsed B-cell lymphoma. The IDEC-C2B8 Study Group.

M. Narabayashi, Y. Kagami, M. Ogura, 1998, Annals of oncology : official journal of the European Society for Medical Oncology.

Dose--volume metrics associated with radiation pneumonitis after stereotactic body radiation therapy for lung cancer.

Mitsuhiro Nakamura, Masahiro Hiraoka, Yasushi Nagata, 2012, International journal of radiation oncology, biology, physics.

Association of UGT2B7 and ABCB1 genotypes with morphine-induced adverse drug reactions in Japanese patients with cancer

Y. Okazaki, M. Narabayashi, Y. Ando, 2009, Cancer Chemotherapy and Pharmacology.

Novel single nucleotide polymorphism of UGT1A9 gene in Japanese.

M. Narabayashi, Y. Ando, Y. Sasaki, 2006, Drug metabolism and pharmacokinetics.

Clinical characteristics of patients with metastatic breast cancer with complete remission following systemic treatment.

M. Narabayashi, Y. Omuro, N. Yamamoto, 1998, Japanese journal of clinical oncology.

Differences in clinicopathological characteristics and major prognostic factors between B-lymphoma and peripheral T-lymphoma excluding adult T-cell leukemia/lymphoma.

M. Narabayashi, K. Tobinai, K. Takeyama, 1993, Leukemia & lymphoma.

Low-dose granulocyte colony-stimulating factor enables the efficient collection of peripheral blood stem cells after disease-oriented, conventional-dose chemotherapy for breast cancer, malignant lymphoma and germ cell tumor.

M. Narabayashi, K. Tobinai, K. Takeyama, 1995, Bone marrow transplantation.

Geometrical differences in target volumes between slow CT and 4D CT imaging in stereotactic body radiotherapy for lung tumors in the upper and middle lobe.

Mitsuhiro Nakamura, Masahiro Hiraoka, Yasushi Nagata, 2008, Medical physics.

M. Narabayashi, K. Tobinai, K. Togitani, 1999, Japanese journal of clinical oncology.

Primary low-grade lymphoma of mucosa-associated lymphoid tissue of the urinary bladder: a case report with special reference to the use of ancillary diagnostic studies.

Y. Kanai, Y. Matsuno, M. Narabayashi, 1999, Japanese journal of clinical oncology.

Histology according to the Revised European-American Lymphoma Classification significantly predicts the prognosis of ocular adnexal lymphoma.

Y. Matsuno, M. Narabayashi, K. Tobinai, 1999, Leukemia & lymphoma.

Thrombotic microangiopathy of hyperacute onset after autologous peripheral blood stem cell transplantation in malignant lymphoma

M. Narabayashi, K. Tobinai, K. Togitani, 1998, Bone Marrow Transplantation.

Reversible posterior leukoencephalopathy syndrome associated with mFOLFOX6 chemotherapy

M. Narabayashi, K. Yamashita, Y. Sasaki, 2012, International Cancer Conference Journal.

High dose chemotherapy followed by autologous bone marrow transplantation (ABMT) and daily infusion of granulocyte colony stimulating factor (G-CSF) for malignant tumors in adults.

M. Narabayashi, K. Tamayose, K. Tobinai, 1991 .

A Dose-finding Study of Lenograstim (Glycosylated rHuG-CSF) for Peripheral Blood Stem Cell Mobilization during Postoperative Adjuvant Chemotherapy in Patients with Breast Cancer

M. Narabayashi, M. Ogura, T. Fukutomi, 1999 .

Randomized phase III and extension studies: efficacy and impacts on quality of life of naldemedine in subjects with opioid-induced constipation and cancer

M. Tsutsumi, M. Narabayashi, T. Harada, 2018, Annals of oncology : official journal of the European Society for Medical Oncology.

Phase IIb, Randomized, Double-Blind, Placebo-Controlled Study of Naldemedine for the Treatment of Opioid-Induced Constipation in Patients With Cancer.

M. Narabayashi, N. Katakami, N. Boku, 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Opioid rotation from oral morphine to oral oxycodone in cancer patients with intolerable adverse effects: an open-label trial.

M. Narabayashi, S. Takenoshita, T. Kamoto, 2008, Japanese journal of clinical oncology.

Phase I/II study of FOLFIRI in Japanese patients with advanced colorectal cancer.

M. Ando, M. Narabayashi, K. Yamashita, 2011, Japanese journal of clinical oncology.

Title The dependency of compound biological effectiveness factors on the type and the concentration of administered neutron capture agents in boron neutron capture therapy

M. Narabayashi, K. Ono, Minoru Suzuki, 2017 .

The dependency of compound biological effectiveness factors on the type and the concentration of administered neutron capture agents in boron neutron capture therapy

M. Narabayashi, K. Ono, Minoru Suzuki, 2014, SpringerPlus.

A phase II study of lapatinib for brain metastases in patients with HER2-overexpressing breast cancer following trastuzumab based systemic therapy and cranial radiotherapy: subset analysis of Japanese patients

H. Iwata, Y. Fujiwara, M. Narabayashi, 2013, International Journal of Clinical Oncology.

Follicular dendritic cells in malignant lymphomas--distribution, phenotypes & ultrastructures.

M. Narabayashi, M. Matsuda, K. Maeda, 1993, Advances in experimental medicine and biology.

Psychological distress following first recurrence of disease in patients with breast cancer: prevalence and risk factors

M. Narabayashi, H. Okamura, T. Akechi, 2000, Breast Cancer Research and Treatment.

Effect of audio coaching on correlation of abdominal displacement with lung tumor motion.

Mitsuhiro Nakamura, Masahiro Hiraoka, Yasushi Nagata, 2009, International journal of radiation oncology, biology, physics.

Detailed dosimetric evaluation of intensity-modulated radiation therapy plans created for stage C prostate cancer based on a planning protocol

M. Hiraoka, M. Narabayashi, Y. Nagata, 2012, International Journal of Clinical Oncology.

Activation syndrome caused by paroxetine in a cancer patient

M. Narabayashi, M. Wada, Hideki Onishi, 2008, Palliative and Supportive Care.

Recurrence patterns and progression-free survival after chemoradiotherapy with or without consolidation durvalumab for stage III non-small cell lung cancer

T. Hirai, M. Ogura, M. Narabayashi, 2022, Journal of radiation research.

Sister Mary Joseph's Nodule From Renal Cell Carcinoma: A Case Report

Kimiko Hirata, M. Narabayashi, T. Segawa, 2022, Cureus.

Drug-induced akathisia as a cause of distress in spouse caregivers of cancer patients

M. Narabayashi, Y. Iwamitsu, K. Mizuno, 2011, Palliative and Supportive Care.

A case of respiratory akathisia in a cancer patient: A case report

M. Narabayashi, W. Ichikawa, Y. Sasaki, 2008, Palliative and Supportive Care.

Psychological distress of the bereaved seeking medical counseling at a cancer center.

M. Narabayashi, Y. Uchitomi, Y. Sasaki, 2012, Japanese journal of clinical oncology.

Stereotactic Body Radiotherapy for the Lung

M. Hiraoka, M. Narabayashi, K. Shibuya, 2011 .

Pharmacokinetics of 5-Fluorouracil in Elderly Japanese Patients with Cancer Treated with S-1 (a Combination of Tegafur and Dihydropyrimidine Dehydrogenase Inhibitor 5-Chloro-2,4-dihydroxypyridine)

M. Narabayashi, K. Yamashita, Y. Ando, 2009, Drug Metabolism and Disposition.

Effect of Tirapazamine and Mild Temperature Hyperthermia on the Recovery from Radiation-Induced Damage in Pimonidazole-Unlabeled Quiescent Tumor Cell Population

M. Narabayashi, K. Ono, Minoru Suzuki, 2013 .

Dosimetric evaluation of the impacts of different heterogeneity correction algorithms on target doses in stereotactic body radiation therapy for lung tumors

Mitsuhiro Nakamura, Masahiro Hiraoka, Takashi Mizowaki, 2012, Journal of radiation research.

Psychiatric disorders in patients who lost family members to cancer and asked for medical help: descriptive analysis of outpatient services for bereaved families at Japanese cancer center hospital.

M. Narabayashi, Y. Uchitomi, Y. Sasaki, 2011, Japanese journal of clinical oncology.

Wortmannin efficiently suppresses the recovery from radiation-induced damage in pimonidazole-unlabeled quiescent tumor cell population

M. Narabayashi, K. Ono, Minoru Suzuki, 2012, Journal of radiation research.

Psychiatric disorders in patients who lost family members to cancer and asked for medical help: descriptive analysis of outpatient services for bereaved families at Japanese cancer center hospital.

M. Narabayashi, Y. Uchitomi, Y. Sasaki, 2011, Japanese journal of clinical oncology.